Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Nature Communications|October 19, 2021
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapyHussein A Abbas, Dapeng Hao, Katarzyna Tomczak, et al.
The Journal of Experimental Medicine|September 30, 2024
An iron-rich subset of macrophages promotes tumor growth through a Bach1-Ednrb axisIan W Folkert, William A Molina Arocho, Tsun Ki Jerrick To, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Spatially-resolved single cell atlas of liposarcoma reveals lineage hierarchies, immune niches, and regulatory circuitsRyan A Denu, Veena Kochat, Zhao Zheng, et al.
Acta Neuropathologica|July 20, 2021
Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated stateVeena Kochat, Ayush T Raman, Sharon M Landers, et al.
Nature Communications|September 22, 2020
Telomere dysfunction activates YAP1 to drive tissue inflammationDeepavali Chakravarti, Baoli Hu, Xizeng Mao, et al.
Nature Communications|July 9, 2022
Multi-modal molecular programs regulate melanoma cell stateMiles C Andrews, Junna Oba, Chang-Jiun Wu, et al.
Cancer Discovery|April 21, 2026
Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II studySalah-Eddine Bentebibel, Daniel J McGrail, Veena Kochat, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancerFrancesca Citron, I-Lin Ho, Chiara Balestrieri, et al.
Science Translational Medicine|September 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AMLBijender Kumar, Anand Singh, Rafet Basar, et al.
Cancer Cell|May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interceptionBo Zhu, Pingjun Chen, Muhammad Aminu, et al.
Pageof 9